Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Top Ten Searches
gynecomastia empyema henoch–schönlein otitis media dyspnea jaundice ventricle lyme immunodeficiency coolingYour Article Summary
Radiation dose and breast cancer risk in the Childhood Cancer Survivor Study
Journal of Clinical Oncology, 07/23/09
Inskip PD et al. - In a trial to quantify the risk of breast cancer in relation to radiation dose and chemotherapy among survivors of childhood cancer, results confirm the radiation sensitivity of the breast in girls age 10 to 20 yrs but do not demonstrate a strong effect of age at exposure within this range. Irradiation of the ovaries at doses >5 Gy seems to lessen carcinogenic effects of breast irradiation, most likely by reducing exposure of radiation-damaged breast cells to stimulating effects of ovarian hormones.
Methods- A study of breast cancer was conducted in a cohort of 6647 women who were 5-yr survivors of childhood cancer and who were treated during 1970 through 1986.
- 120 pts with histologically confirmed breast cancer were identified and were individually matched to 4 selected controls on age at initial cancer and time since initial cancer.
- Medical physicists estimated radiation dose to the breast tumor site and ovaries on the basis of medical records.
- The odds ratio for breast cancer increased linearly with radiation dose, and it reached 11-fold for local breast doses of approximately 40 Gy relative to no radiation.
- Risk associated with breast irradiation was sharply reduced among women who received ≥5 Gy to the ovaries.
- Excess odds ratio per Gy was 0.36 for those who received ovarian doses <5 Gy and was 0.06 for those who received higher doses.
- Radiation-related risk did not vary significantly by age at exposure.
- Borderline significantly elevated risks were seen for doxorubicin, dactinomycin, dacarbazine, and carmustine.
Related Articles
Radiation Therapy After Lumpectomy For Breast Cancer Can Be Safely Reduced To 4 Weeks
ScienceDaily, 11/05/09
Relevance Score: 89%
Radiation Therapy Technique Successfully Treats Pain In Patients With Advanced Cancer
ScienceDaily, 11/04/09
Relevance Score: 89%
Radiation Treatments Made Safer for Cancer Patients
MedLinePlus, 10/23/09
Relevance Score: 89%
In utero exposure to therapeutic radiation for Hodgkin lymphoma
Canadian Family Physician, 10/14/09
Relevance Score: 89%
Ovarian ablation by radiation therapy: Is it still an option for the ablation of ovarian function in endocrine responsive premenopausal breast cancer patients?
The Breast, 10/08/09
Relevance Score: 89%
Today in Pediatric Heme/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Duodenum-Sparing Technique of Head Resection in Solid Pseudopapillary Tumor of the Pancreas in Children
European Journal of Pediatric Surgery, 12/20/09
Fetal Brain Hemodynamic Changes in Intrauterine Transfusion: Influence of Needle Puncture Site
Fetal Diagnosis and Therapy, 12/20/09
Initial testing of topotecan by the pediatric preclinical testing program
Pediatric Blood & Cancer, 12/18/09
Today in Pediatric Radiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Initial experience with a radiology imaging network to newborn and intensive care units
Journal of Digital Imaging, 12/19/09
Conservative Management in Three Cases of Prenatally Recognized Splenic Cyst Using 2D, 3D, Multi-Slice and Doppler Ultrasonography
Fetal Diagnosis and Therapy, 12/19/09
What are the clinical and radiological characteristics of spinal injuries from physical abuse: a systematic review
BMJ - Archives of Diseases in Childhood, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


